Imatinib effect on Philadelphia chromosome positive acute lymphoblastic leukemia cells
Transcriptomics Dataset
FAIR Metrics
0 evaluations
General Information
| Accession | GSE23743 |
| Title | Imatinib effect on Philadelphia chromosome positive acute lymphoblastic leukemia cells |
| Description | Analysis of Ph+ ALL cell lines (BV-173, NALM-1, SUP-B15, and TOM1) treated with tyrosine kinase inhibitor (TKI) imatinib. Ph encodes oncogenic BCR-ABL1 tyrosine kinase, which defines a subset of ALL with an unfavorable prognosis. Results provide insight into TKI resistance mechanisms in Ph+ ALL. |
| Landing Page | https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE23743 |
| Repository | Gene Expression Omnibus |
Tools
used to analyze the dataset
Canned Analyses
generated with the dataset
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.
